Washington CannaBusiness Association
(WACA)

Director Rick Garza shared some observations with attendees, focusing on vertical integration, cannabinoid regulation, medical cannabis, and social equity before taking questions.

Cannabis trade associations shared their legislative priorities around out-of-state ownership, social equity, medical cannabis, and synthesized cannabinoids.

Prevention and social equity advocates would convene online, while a cannabis trade association would host state legislators, regulators, and researchers for in person discussion.

Director of Legislative Relations Chris Thompson went over the status of two potential agency request bills (lab standards, cannabinoid regulation) and an upcoming briefing to lawmakers.

Director of Policy and External Affairs Justin Nordhorn discussed the background, intent, and changes requested in draft legislation on “psychotropic” and “impairing” cannabis compounds.

Industry, academic, and agency representatives brought lawmakers up to speed on CBD product research and policy development in Washington state.

WSLCB Director Rick Garza shared new details about the background, leadership, and advocacy of CANNRA as he encouraged traffic safety officials to affiliate with the organization.

Staff described outreach to a U.S. Senator, participation in the spring meeting of a prominent cannabis organization, and planned revisions to the scope of rulemaking on synthesized cannabinoids.

Details of a board member’s discussion with state counsel on synthesized delta-9-THC led to conversation about the policy statements and agency regulatory powers beyond rulemaking.

Members asked about the potential to include consideration of synthesized delta-9-THC in open rulemaking and had a lengthy discussion on the tone of official statements on the matter.